39 related articles for article (PubMed ID: 8185007)
1. Natural Medicines for Psychotic Disorders: A Systematic Review.
Hoenders HJR; Bartels-Velthuis AA; Vollbehr NK; Bruggeman R; Knegtering H; de Jong JTVM
J Nerv Ment Dis; 2018 Feb; 206(2):81-101. PubMed ID: 29373456
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E for antipsychotic-induced tardive dyskinesia.
Soares-Weiser K; Maayan N; Bergman H
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000209. PubMed ID: 29341067
[TBL] [Abstract][Full Text] [Related]
3. Antioxidants as potential therapeutics for neuropsychiatric disorders.
Pandya CD; Howell KR; Pillai A
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():214-23. PubMed ID: 23123357
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.
Bjelakovic G; Nikolova D; Gluud LL; Simonetti RG; Gluud C
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD007176. PubMed ID: 22419320
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress in schizophrenia.
Bošković M; Vovk T; Kores Plesničar B; Grabnar I
Curr Neuropharmacol; 2011 Jun; 9(2):301-12. PubMed ID: 22131939
[TBL] [Abstract][Full Text] [Related]
6. Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats.
Fachinetto R; Villarinho JG; Wagner C; Pereira RP; Puntel RL; Paixão MW; Braga AL; Calixto JB; Rocha JB; Ferreira J
Psychopharmacology (Berl); 2007 Oct; 194(3):423-32. PubMed ID: 17641876
[TBL] [Abstract][Full Text] [Related]
7. Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.
Pierre JM
Drug Saf; 2005; 28(3):191-208. PubMed ID: 15733025
[TBL] [Abstract][Full Text] [Related]
8. Tardive Dyskinesia.
Tarsy D
Curr Treat Options Neurol; 2000 May; 2(3):205-214. PubMed ID: 11096748
[TBL] [Abstract][Full Text] [Related]
9. Vitamin E updated.
Matthai J
Indian J Pediatr; 1996; 63(2):242-53. PubMed ID: 10829996
[TBL] [Abstract][Full Text] [Related]
10. Managing antipsychotic-induced acute and tardive dystonia.
Raja M
Drug Saf; 1998 Jul; 19(1):57-72. PubMed ID: 9673858
[TBL] [Abstract][Full Text] [Related]
11. Melatonin, sleep, aging, and the health protection branch.
Young SN
J Psychiatry Neurosci; 1996 May; 21(3):161-4. PubMed ID: 8935327
[No Abstract] [Full Text] [Related]
12. Treatment of tardive dyskinesia with vitamin E.
Egan MF; Hyde TM; Albers GW; Elkashef A; Alexander RC; Reeve A; Blum A; Saenz RE; Wyatt RJ
Am J Psychiatry; 1992 Jun; 149(6):773-7. PubMed ID: 1350428
[TBL] [Abstract][Full Text] [Related]
13. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
Lohr JB; Caligiuri MP
J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E treatment of tardive dyskinesia.
Adler LA; Peselow E; Rotrosen J; Duncan E; Lee M; Rosenthal M; Angrist B
Am J Psychiatry; 1993 Sep; 150(9):1405-7. PubMed ID: 8102511
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E in tardive dyskinesia.
Schneiderhan ME
Ann Pharmacother; 1993 Mar; 27(3):311-3. PubMed ID: 8453169
[No Abstract] [Full Text] [Related]
16. Oxidative mechanisms and tardive dyskinesia.
Lohr JB; Kuczenski R; Niculescu AB
CNS Drugs; 2003; 17(1):47-62. PubMed ID: 12467492
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of vitamin E for treatment of long-term tardive dyskinesia.
Dabiri LM; Pasta D; Darby JK; Mosbacher D
Am J Psychiatry; 1994 Jun; 151(6):925-6. PubMed ID: 8185007
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
